1 active not recruiting, 1 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow flibanserin: new trials by email Literature Review of flibanserin trials Research Report on flibanserin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer Flibanserin 100 MG, Placebo, Androgen deprivation therapy - Prostate Adenocarcinoma | Phase 2 | Completed | Andrew McDonald | 44 | 2021-07-02 | 2026-07-20 |
| Hypoactive Sexual Desire Disorder in Males Flibanserin, Placebo - Low Libido | Phase 2 | Terminated | Mohit Khera | 8 | 2020-05-08 | 2026-01-26 |
| A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors Flibanserin Pill - Breast Cancer, Hyposexual Desire Disorder | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 43 | 2018-09-14 | 2026-11-04 |
Breast Neoplasms (1) · Erectile Dysfunction (1)
Andrew McDonald (1) · Memorial Sloan Kettering Cancer Center (1) · Mohit Khera (1)
United States (3)
Andrew McDonald, MD (1) · Mohit Khera, MD, MBA, MPH (1) · Shari Goldfarb, MD (1)
R21CA259808 (1)